Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)

Beacon Pharmaceuticals Revenue

Beacon Pharmaceuticals had revenue of 3.18B BDT in the quarter ending December 31, 2024, with 14.18% growth. This brings the company's revenue in the last twelve months to 11.58B, up 23.15% year-over-year. In the fiscal year ending June 30, 2024, Beacon Pharmaceuticals had annual revenue of 10.70B with 25.76% growth.

• Revenue (ttm): 11.58B
• Revenue Growth: +23.15%
• P/S Ratio: 2.04
• Revenue / Employee: 2.78M
• Employees: 4,162
• Market Cap: 23.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	10.70B	2.19B	25.76%
Jun 30, 2023	8.51B	487.21M	6.07%
Jun 30, 2022	8.02B	901.58M	12.66%
Jun 30, 2021	7.12B	1.53B	27.37%
Jun 30, 2020	5.59B	943.92M	20.31%